hexamethonium has been researched along with Infant, Premature, Diseases in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HALLUM, JL | 1 |
| HATCHUEL, WL | 1 |
1 other study available for hexamethonium and Infant, Premature, Diseases
| Article | Year |
|---|---|
Congenital paralytic ielus in a premature baby as a complication of hexamethonium bromide therapy for toxaemia of pregnancy.
Topics: Child; Female; Hexamethonium; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, | 1954 |